| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | water channel activity | 6.17e-05 | 17 | 14 | 2 | GO:0015250 | |
| GeneOntologyMolecularFunction | water transmembrane transporter activity | 8.61e-05 | 20 | 14 | 2 | GO:0005372 | |
| GeneOntologyMolecularFunction | nuclear retinoid X receptor binding | 1.15e-04 | 23 | 14 | 2 | GO:0046965 | |
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 6.64e-04 | 55 | 14 | 2 | GO:0042974 | |
| GeneOntologyMolecularFunction | histone deacetylase binding | 4.62e-03 | 147 | 14 | 2 | GO:0042826 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 7.37e-03 | 187 | 14 | 2 | GO:0016922 | |
| GeneOntologyMolecularFunction | transcription corepressor activity | 1.09e-02 | 229 | 14 | 2 | GO:0003714 | |
| GeneOntologyBiologicalProcess | negative regulation of androgen receptor signaling pathway | 5.78e-05 | 17 | 14 | 2 | GO:0060766 | |
| GeneOntologyBiologicalProcess | negative regulation of miRNA transcription | 1.97e-04 | 31 | 14 | 2 | GO:1902894 | |
| GeneOntologyBiologicalProcess | regulation of androgen receptor signaling pathway | 1.97e-04 | 31 | 14 | 2 | GO:0060765 | |
| GeneOntologyBiologicalProcess | water transport | 2.10e-04 | 32 | 14 | 2 | GO:0006833 | |
| GeneOntologyBiologicalProcess | negative regulation of miRNA metabolic process | 2.37e-04 | 34 | 14 | 2 | GO:2000629 | |
| GeneOntologyBiologicalProcess | negative regulation of intracellular steroid hormone receptor signaling pathway | 3.29e-04 | 40 | 14 | 2 | GO:0033144 | |
| GeneOntologyBiologicalProcess | establishment of skin barrier | 3.46e-04 | 41 | 14 | 2 | GO:0061436 | |
| GeneOntologyBiologicalProcess | fluid transport | 3.63e-04 | 42 | 14 | 2 | GO:0042044 | |
| GeneOntologyBiologicalProcess | androgen receptor signaling pathway | 5.35e-04 | 51 | 14 | 2 | GO:0030521 | |
| GeneOntologyCellularComponent | histone deacetylase complex | 1.66e-03 | 85 | 15 | 2 | GO:0000118 | |
| GeneOntologyCellularComponent | transcription repressor complex | 1.74e-03 | 87 | 15 | 2 | GO:0017053 | |
| HumanPheno | Reticular pattern on pulmonary HRCT | 6.98e-05 | 14 | 5 | 2 | HP:0025390 | |
| HumanPheno | Honeycomb lung | 6.98e-05 | 14 | 5 | 2 | HP:0025175 | |
| HumanPheno | Orthodeoxia | 6.98e-05 | 14 | 5 | 2 | HP:0033367 | |
| HumanPheno | Usual interstitial pneumonia | 8.05e-05 | 15 | 5 | 2 | HP:0031950 | |
| HumanPheno | Subpleural honeycombing | 9.20e-05 | 16 | 5 | 2 | HP:0031631 | |
| HumanPheno | Abnormal subpleural morphology | 1.04e-04 | 17 | 5 | 2 | HP:0031630 | |
| HumanPheno | Multiple pulmonary cysts | 1.61e-04 | 21 | 5 | 2 | HP:0005948 | |
| HumanPheno | Crackles | 2.29e-04 | 25 | 5 | 2 | HP:0030830 | |
| HumanPheno | Ground-glass opacification | 2.29e-04 | 25 | 5 | 2 | HP:0025179 | |
| HumanPheno | Decreased DLCO | 2.48e-04 | 26 | 5 | 2 | HP:0045051 | |
| HumanPheno | Abnormal DLCO | 2.48e-04 | 26 | 5 | 2 | HP:0045049 | |
| HumanPheno | Pulmonary opacity | 2.48e-04 | 26 | 5 | 2 | HP:0031457 | |
| HumanPheno | Pulmonic regurgitation | 2.68e-04 | 27 | 5 | 2 | HP:0010444 | |
| HumanPheno | Exercise intolerance | 2.69e-04 | 156 | 5 | 3 | HP:0003546 | |
| HumanPheno | Pulmonary interstitial high-resolution computed tomography abnormality | 2.88e-04 | 28 | 5 | 2 | HP:0025389 | |
| HumanPheno | Cough | 2.90e-04 | 160 | 5 | 3 | HP:0012735 | |
| HumanPheno | Abnormal pulmonary interstitial morphology | 2.96e-04 | 161 | 5 | 3 | HP:0006530 | |
| HumanPheno | Persistent head lag | 3.78e-04 | 32 | 5 | 2 | HP:0032988 | |
| HumanPheno | Pulmonary cyst | 4.27e-04 | 34 | 5 | 2 | HP:0032445 | |
| HumanPheno | Acrocyanosis | 4.79e-04 | 36 | 5 | 2 | HP:0001063 | |
| HumanPheno | Gastroesophageal reflux | 4.83e-04 | 517 | 5 | 4 | HP:0002020 | |
| HumanPheno | Peripheral cyanosis | 5.34e-04 | 38 | 5 | 2 | HP:0034033 | |
| HumanPheno | Reduced forced vital capacity | 5.34e-04 | 38 | 5 | 2 | HP:0032341 | |
| HumanPheno | Clubbing of fingers | 5.63e-04 | 39 | 5 | 2 | HP:0100759 | |
| HumanPheno | Abnormal blood oxygen level | 8.54e-04 | 48 | 5 | 2 | HP:0500165 | |
| HumanPheno | Hypoxemia | 8.54e-04 | 48 | 5 | 2 | HP:0012418 | |
| HumanPheno | Abnormal blood gas level | 1.04e-03 | 53 | 5 | 2 | HP:0012415 | |
| HumanPheno | Respiratory failure | 1.25e-03 | 262 | 5 | 3 | HP:0002878 | |
| HumanPheno | Emphysema | 1.52e-03 | 64 | 5 | 2 | HP:0002097 | |
| HumanPheno | Abnormal stomach morphology | 1.98e-03 | 742 | 5 | 4 | HP:0002577 | |
| HumanPheno | Pulmonary fibrosis | 2.25e-03 | 78 | 5 | 2 | HP:0002206 | |
| MousePheno | increased susceptibility to induced pancreatitis | 4.81e-05 | 15 | 10 | 2 | MP:0004761 | |
| MousePheno | abnormal pancreatic acinar cell zymogen granule morphology | 6.23e-05 | 17 | 10 | 2 | MP:0009160 | |
| MousePheno | increased epididymal fat pad weight | 2.26e-04 | 32 | 10 | 2 | MP:0009288 | |
| MousePheno | abnormal pancreatic acinar cell morphology | 3.72e-04 | 41 | 10 | 2 | MP:0009146 | |
| MousePheno | abnormal pancreatic acinus morphology | 4.09e-04 | 43 | 10 | 2 | MP:0009145 | |
| Domain | GPS2_interact | 5.22e-07 | 2 | 14 | 2 | PF15784 | |
| Domain | Aquaporin_12 | 5.22e-07 | 2 | 14 | 2 | IPR023265 | |
| Domain | N-CoR_GPS2_interact | 5.22e-07 | 2 | 14 | 2 | IPR031557 | |
| Domain | Aquaporin_11/12 | 1.56e-06 | 3 | 14 | 2 | IPR016697 | |
| Domain | MIP | 4.72e-05 | 14 | 14 | 2 | PF00230 | |
| Domain | MIP | 4.72e-05 | 14 | 14 | 2 | PS00221 | |
| Domain | - | 5.45e-05 | 15 | 14 | 2 | 1.20.1080.10 | |
| Domain | Aquaporin-like | 5.45e-05 | 15 | 14 | 2 | IPR023271 | |
| Domain | MIP | 5.45e-05 | 15 | 14 | 2 | IPR000425 | |
| Domain | SANT_dom | 1.68e-04 | 26 | 14 | 2 | IPR017884 | |
| Domain | SANT | 1.95e-04 | 28 | 14 | 2 | PS51293 | |
| Domain | Myb_DNA-binding | 3.06e-04 | 35 | 14 | 2 | PF00249 | |
| Domain | MYB_LIKE | 3.61e-04 | 38 | 14 | 2 | PS50090 | |
| Domain | SANT | 6.26e-04 | 50 | 14 | 2 | SM00717 | |
| Domain | SANT/Myb | 6.77e-04 | 52 | 14 | 2 | IPR001005 | |
| Domain | - | 1.85e-02 | 283 | 14 | 2 | 1.10.10.60 | |
| Domain | Homeodomain-like | 2.49e-02 | 332 | 14 | 2 | IPR009057 | |
| Pathway | REACTOME_LOSS_OF_MECP2_BINDING_ABILITY_TO_THE_NCOR_SMRT_COMPLEX | 1.64e-05 | 7 | 13 | 2 | M27899 | |
| Pathway | PID_ERA_GENOMIC_PATHWAY | 2.47e-05 | 64 | 13 | 3 | M200 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_CONTROL_BILE_ACID_HOMEOSTASIS | 2.82e-05 | 9 | 13 | 2 | M29809 | |
| Pathway | REACTOME_PASSIVE_TRANSPORT_BY_AQUAPORINS | 6.09e-05 | 13 | 13 | 2 | MM15095 | |
| Pathway | REACTOME_LOSS_OF_FUNCTION_OF_MECP2_IN_RETT_SYNDROME | 6.09e-05 | 13 | 13 | 2 | M29766 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 2.93e-04 | 28 | 13 | 2 | M6177 | |
| Pathway | REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY | 3.60e-04 | 31 | 13 | 2 | M669 | |
| Pathway | REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY | 3.83e-04 | 32 | 13 | 2 | M27900 | |
| Pathway | REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX | 5.13e-04 | 37 | 13 | 2 | M29790 | |
| Pathway | REACTOME_AQUAPORIN_MEDIATED_TRANSPORT | 6.00e-04 | 40 | 13 | 2 | MM15115 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 8.29e-04 | 47 | 13 | 2 | M29777 | |
| Pathway | PID_HES_HEY_PATHWAY | 8.65e-04 | 48 | 13 | 2 | M288 | |
| Pathway | WP_RETT_SYNDROME | 8.65e-04 | 48 | 13 | 2 | M39759 | |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 8.65e-04 | 48 | 13 | 2 | M611 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER | 9.76e-04 | 51 | 13 | 2 | M665 | |
| Pathway | BIOCARTA_PPARA_PATHWAY | 1.01e-03 | 52 | 13 | 2 | M2404 | |
| Pathway | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | 1.05e-03 | 53 | 13 | 2 | M8276 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER | 1.26e-03 | 58 | 13 | 2 | M29616 | |
| Pathway | PID_NOTCH_PATHWAY | 1.30e-03 | 59 | 13 | 2 | M17 | |
| Pathway | REACTOME_CYTOPROTECTION_BY_HMOX1 | 1.35e-03 | 60 | 13 | 2 | M41830 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 1.39e-03 | 61 | 13 | 2 | M39540 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2 | 1.49e-03 | 63 | 13 | 2 | M27862 | |
| Pathway | PID_HDAC_CLASSI_PATHWAY | 1.63e-03 | 66 | 13 | 2 | M101 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 1.76e-03 | 272 | 13 | 3 | M29619 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 2.04e-03 | 74 | 13 | 2 | M616 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 2.50e-03 | 82 | 13 | 2 | MM15922 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | 2.62e-03 | 84 | 13 | 2 | M1008 | |
| Pathway | WP_ANDROGEN_RECEPTOR_SIGNALING | 3.07e-03 | 91 | 13 | 2 | M39700 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 3.27e-03 | 94 | 13 | 2 | M1041 | |
| Pathway | REACTOME_HDACS_DEACETYLATE_HISTONES | 3.27e-03 | 94 | 13 | 2 | M27230 | |
| Pathway | REACTOME_ADIPOGENESIS | 4.45e-03 | 110 | 13 | 2 | M48259 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 5.10e-03 | 118 | 13 | 2 | M27316 | |
| Pathway | WP_ADIPOGENESIS | 6.25e-03 | 131 | 13 | 2 | M39505 | |
| Pathway | WP_ADIPOGENESIS_GENES | 6.82e-03 | 137 | 13 | 2 | MM15970 | |
| Pathway | REACTOME_HCMV_EARLY_EVENTS | 6.91e-03 | 138 | 13 | 2 | M29805 | |
| Pathway | WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME | 7.61e-03 | 145 | 13 | 2 | M45512 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 9.31e-03 | 161 | 13 | 2 | M27871 | |
| Pathway | REACTOME_HCMV_INFECTION | 9.42e-03 | 162 | 13 | 2 | M29804 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 1.09e-02 | 175 | 13 | 2 | MM14941 | |
| Pubmed | 1.74e-07 | 2 | 15 | 2 | 21131350 | ||
| Pubmed | 1.74e-07 | 2 | 15 | 2 | 36167651 | ||
| Pubmed | Regulation of corepressor alternative mRNA splicing by hormonal and metabolic signaling. | 1.74e-07 | 2 | 15 | 2 | 26166430 | |
| Pubmed | 1.74e-07 | 2 | 15 | 2 | 22944139 | ||
| Pubmed | 1.74e-07 | 2 | 15 | 2 | 19299558 | ||
| Pubmed | Unique forms of human and mouse nuclear receptor corepressor SMRT. | 1.74e-07 | 2 | 15 | 2 | 10077563 | |
| Pubmed | 1.74e-07 | 2 | 15 | 2 | 29531310 | ||
| Pubmed | Evolution of NCoR-1 and NCoR-2 corepressor alternative mRNA splicing in placental mammals. | 1.74e-07 | 2 | 15 | 2 | 31208445 | |
| Pubmed | CREBBP Inactivation Promotes the Development of HDAC3-Dependent Lymphomas. | 1.74e-07 | 2 | 15 | 2 | 27733359 | |
| Pubmed | Identification of a novel aquaporin, AQP12, expressed in pancreatic acinar cells. | 1.74e-07 | 2 | 15 | 2 | 15809071 | |
| Pubmed | 1.74e-07 | 2 | 15 | 2 | 19726746 | ||
| Pubmed | 1.74e-07 | 2 | 15 | 2 | 39106294 | ||
| Pubmed | 5.21e-07 | 3 | 15 | 2 | 22337871 | ||
| Pubmed | 5.21e-07 | 3 | 15 | 2 | 15802375 | ||
| Pubmed | Functional interactions with Pit-1 reorganize co-repressor complexes in the living cell nucleus. | 5.21e-07 | 3 | 15 | 2 | 16030140 | |
| Pubmed | 5.21e-07 | 3 | 15 | 2 | 34390859 | ||
| Pubmed | Oligomerization of ETO is obligatory for corepressor interaction. | 5.21e-07 | 3 | 15 | 2 | 11113190 | |
| Pubmed | 5.21e-07 | 3 | 15 | 2 | 36238311 | ||
| Pubmed | 5.21e-07 | 3 | 15 | 2 | 10406466 | ||
| Pubmed | 5.21e-07 | 3 | 15 | 2 | 36316474 | ||
| Pubmed | Nuclear receptor co-repressors are required for the histone-deacetylase activity of HDAC3 in vivo. | 5.21e-07 | 3 | 15 | 2 | 23292142 | |
| Pubmed | Involvement of SMRT corepressor in transcriptional repression by the vitamin D receptor. | 5.21e-07 | 3 | 15 | 2 | 19098224 | |
| Pubmed | 5.21e-07 | 3 | 15 | 2 | 18052923 | ||
| Pubmed | 5.21e-07 | 3 | 15 | 2 | 15016838 | ||
| Pubmed | 5.21e-07 | 3 | 15 | 2 | 16373395 | ||
| Pubmed | 5.21e-07 | 3 | 15 | 2 | 11997503 | ||
| Pubmed | 5.21e-07 | 3 | 15 | 2 | 24268577 | ||
| Pubmed | 5.21e-07 | 3 | 15 | 2 | 31404087 | ||
| Pubmed | 5.21e-07 | 3 | 15 | 2 | 12011091 | ||
| Pubmed | 5.21e-07 | 3 | 15 | 2 | 21518914 | ||
| Pubmed | 5.21e-07 | 3 | 15 | 2 | 18852122 | ||
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 9.89e-07 | 184 | 15 | 4 | 32908313 | |
| Pubmed | MicroRNAs are mediators of androgen action in prostate and muscle. | 1.04e-06 | 4 | 15 | 2 | 21048966 | |
| Pubmed | Transcriptional integration of TLR2 and TLR4 signaling at the NCoR derepression checkpoint. | 1.04e-06 | 4 | 15 | 2 | 19595715 | |
| Pubmed | 1.04e-06 | 4 | 15 | 2 | 9819405 | ||
| Pubmed | Vitamin D-dependent recruitment of corepressors to vitamin D/retinoid X receptor heterodimers. | 1.04e-06 | 4 | 15 | 2 | 18362166 | |
| Pubmed | 1.04e-06 | 4 | 15 | 2 | 18632669 | ||
| Pubmed | Boat, an AXH domain protein, suppresses the cytotoxicity of mutant ataxin-1. | 1.04e-06 | 4 | 15 | 2 | 16121196 | |
| Pubmed | Dichotomous engagement of HDAC3 activity governs inflammatory responses. | 1.04e-06 | 4 | 15 | 2 | 32760002 | |
| Pubmed | 1.04e-06 | 4 | 15 | 2 | 19147680 | ||
| Pubmed | The SMRT and N-CoR corepressors are activating cofactors for histone deacetylase 3. | 1.04e-06 | 4 | 15 | 2 | 11509652 | |
| Pubmed | A SANT motif in the SMRT corepressor interprets the histone code and promotes histone deacetylation. | 1.04e-06 | 4 | 15 | 2 | 12840002 | |
| Pubmed | Nuclear receptor coregulator SNP discovery and impact on breast cancer risk. | 1.04e-06 | 4 | 15 | 2 | 20003447 | |
| Pubmed | A unique secondary-structure switch controls constitutive gene repression by retinoic acid receptor. | 1.04e-06 | 4 | 15 | 2 | 20543827 | |
| Pubmed | 1.04e-06 | 4 | 15 | 2 | 26712002 | ||
| Pubmed | 1.04e-06 | 4 | 15 | 2 | 26712006 | ||
| Pubmed | 1.04e-06 | 4 | 15 | 2 | 32072640 | ||
| Pubmed | NCoR1 and SMRT play unique roles in thyroid hormone action in vivo. | 1.04e-06 | 4 | 15 | 2 | 25421714 | |
| Pubmed | 1.04e-06 | 4 | 15 | 2 | 15878880 | ||
| Pubmed | 1.04e-06 | 4 | 15 | 2 | 19211732 | ||
| Pubmed | FBI-1 functions as a novel AR co-repressor in prostate cancer cells. | 1.04e-06 | 4 | 15 | 2 | 20812024 | |
| Pubmed | Direct association between the CREB-binding protein (CBP) and nuclear receptor corepressor (N-CoR). | 1.04e-06 | 4 | 15 | 2 | 17073437 | |
| Pubmed | 1.04e-06 | 4 | 15 | 2 | 16024608 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 1.25e-06 | 475 | 15 | 5 | 31040226 | |
| Pubmed | Critical residues within the BTB domain of PLZF and Bcl-6 modulate interaction with corepressors. | 1.73e-06 | 5 | 15 | 2 | 11865059 | |
| Pubmed | 1.73e-06 | 5 | 15 | 2 | 15832170 | ||
| Pubmed | Targeting fusion protein/corepressor contact restores differentiation response in leukemia cells. | 1.73e-06 | 5 | 15 | 2 | 15729358 | |
| Pubmed | Combinatorial roles of the nuclear receptor corepressor in transcription and development. | 1.73e-06 | 5 | 15 | 2 | 11030619 | |
| Pubmed | Expression of nuclear receptor corepressors and class I histone deacetylases in astrocytic gliomas. | 1.73e-06 | 5 | 15 | 2 | 21143702 | |
| Pubmed | Genome-Nuclear Lamina Interactions Regulate Cardiac Stem Cell Lineage Restriction. | 1.73e-06 | 5 | 15 | 2 | 29033129 | |
| Pubmed | 1.73e-06 | 5 | 15 | 2 | 7566114 | ||
| Pubmed | ERbeta Binds N-CoR in the Presence of Estrogens via an LXXLL-like Motif in the N-CoR C-terminus. | 1.73e-06 | 5 | 15 | 2 | 12904255 | |
| Pubmed | The histone deacetylase-3 complex contains nuclear receptor corepressors. | 1.73e-06 | 5 | 15 | 2 | 10860984 | |
| Pubmed | A core SMRT corepressor complex containing HDAC3 and TBL1, a WD40-repeat protein linked to deafness. | 1.73e-06 | 5 | 15 | 2 | 10809664 | |
| Pubmed | 1.73e-06 | 5 | 15 | 2 | 30664766 | ||
| Pubmed | Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. | 1.73e-06 | 5 | 15 | 2 | 15175761 | |
| Pubmed | 1.73e-06 | 5 | 15 | 2 | 21088000 | ||
| Pubmed | 1.73e-06 | 5 | 15 | 2 | 16033423 | ||
| Pubmed | Mouse germline restriction of Oct4 expression by germ cell nuclear factor. | 1.73e-06 | 5 | 15 | 2 | 11702949 | |
| Pubmed | 1.73e-06 | 5 | 15 | 2 | 10803578 | ||
| Pubmed | 1.73e-06 | 5 | 15 | 2 | 23703729 | ||
| Pubmed | 1.73e-06 | 5 | 15 | 2 | 16712523 | ||
| Pubmed | 1.73e-06 | 5 | 15 | 2 | 14593076 | ||
| Pubmed | 1.73e-06 | 5 | 15 | 2 | 14985122 | ||
| Pubmed | 1.73e-06 | 5 | 15 | 2 | 15531890 | ||
| Pubmed | Analysis of BCL6-interacting proteins by tandem mass spectrometry. | 2.42e-06 | 62 | 15 | 3 | 16147992 | |
| Pubmed | 2.60e-06 | 6 | 15 | 2 | 12460926 | ||
| Pubmed | 2.60e-06 | 6 | 15 | 2 | 27506116 | ||
| Pubmed | The interaction of the vitamin D receptor with nuclear receptor corepressors and coactivators. | 2.60e-06 | 6 | 15 | 2 | 9878542 | |
| Pubmed | 2.60e-06 | 6 | 15 | 2 | 19955185 | ||
| Pubmed | 2.60e-06 | 6 | 15 | 2 | 18832723 | ||
| Pubmed | MicroRNA cluster 221-222 and estrogen receptor alpha interactions in breast cancer. | 2.60e-06 | 6 | 15 | 2 | 20388878 | |
| Pubmed | 2.60e-06 | 6 | 15 | 2 | 26859354 | ||
| Pubmed | 2.60e-06 | 6 | 15 | 2 | 10640275 | ||
| Pubmed | 2.60e-06 | 6 | 15 | 2 | 9405624 | ||
| Pubmed | 3.64e-06 | 7 | 15 | 2 | 11804585 | ||
| Pubmed | 3.64e-06 | 7 | 15 | 2 | 11867749 | ||
| Pubmed | 3.64e-06 | 7 | 15 | 2 | 29523594 | ||
| Pubmed | 3.64e-06 | 7 | 15 | 2 | 11903058 | ||
| Pubmed | A novel histone deacetylase pathway regulates mitosis by modulating Aurora B kinase activity. | 3.64e-06 | 7 | 15 | 2 | 16980585 | |
| Pubmed | MTA3 and the Mi-2/NuRD complex regulate cell fate during B lymphocyte differentiation. | 3.64e-06 | 7 | 15 | 2 | 15454082 | |
| Pubmed | 3.64e-06 | 7 | 15 | 2 | 18500350 | ||
| Pubmed | 3.64e-06 | 7 | 15 | 2 | 15695367 | ||
| Pubmed | 4.85e-06 | 8 | 15 | 2 | 27068467 | ||
| Pubmed | Role of PML and PML-RARalpha in Mad-mediated transcriptional repression. | 4.85e-06 | 8 | 15 | 2 | 11430826 | |
| Pubmed | 4.85e-06 | 8 | 15 | 2 | 20935208 | ||
| Pubmed | 4.85e-06 | 8 | 15 | 2 | 19786558 | ||
| Pubmed | 4.85e-06 | 8 | 15 | 2 | 10049357 | ||
| Pubmed | A novel POK family transcription factor, ZBTB5, represses transcription of p21CIP1 gene. | 4.85e-06 | 8 | 15 | 2 | 19491398 | |
| Pubmed | Rett syndrome mutations abolish the interaction of MeCP2 with the NCoR/SMRT co-repressor. | 4.85e-06 | 8 | 15 | 2 | 23770565 | |
| Interaction | FEV interactions | 9.24e-06 | 203 | 14 | 4 | int:FEV | |
| Interaction | NFIX interactions | 1.44e-05 | 227 | 14 | 4 | int:NFIX | |
| Interaction | KLF3 interactions | 1.46e-05 | 228 | 14 | 4 | int:KLF3 | |
| Interaction | ASF1A interactions | 2.07e-05 | 249 | 14 | 4 | int:ASF1A | |
| Interaction | HNF4A interactions | 3.05e-05 | 275 | 14 | 4 | int:HNF4A | |
| Interaction | SOX17 interactions | 3.56e-05 | 95 | 14 | 3 | int:SOX17 | |
| Interaction | HCFC1 interactions | 3.91e-05 | 293 | 14 | 4 | int:HCFC1 | |
| Interaction | NUP43 interactions | 4.48e-05 | 625 | 14 | 5 | int:NUP43 | |
| Interaction | ELF4 interactions | 6.29e-05 | 115 | 14 | 3 | int:ELF4 | |
| Interaction | B4GALT2 interactions | 6.97e-05 | 119 | 14 | 3 | int:B4GALT2 | |
| Interaction | SPINT2 interactions | 1.08e-04 | 138 | 14 | 3 | int:SPINT2 | |
| Interaction | HDAC7 interactions | 1.15e-04 | 141 | 14 | 3 | int:HDAC7 | |
| Interaction | NR6A1 interactions | 1.23e-04 | 24 | 14 | 2 | int:NR6A1 | |
| Interaction | NR1D1 interactions | 1.33e-04 | 25 | 14 | 2 | int:NR1D1 | |
| Interaction | SUPT5H interactions | 1.41e-04 | 408 | 14 | 4 | int:SUPT5H | |
| Interaction | DGKG interactions | 1.80e-04 | 29 | 14 | 2 | int:DGKG | |
| Interaction | LHX4 interactions | 1.87e-04 | 166 | 14 | 3 | int:LHX4 | |
| Interaction | SYNE3 interactions | 1.95e-04 | 444 | 14 | 4 | int:SYNE3 | |
| Interaction | EGR2 interactions | 2.04e-04 | 171 | 14 | 3 | int:EGR2 | |
| Interaction | NR1H4 interactions | 2.20e-04 | 32 | 14 | 2 | int:NR1H4 | |
| Interaction | LHX3 interactions | 2.57e-04 | 185 | 14 | 3 | int:LHX3 | |
| Interaction | GATA3 interactions | 2.65e-04 | 187 | 14 | 3 | int:GATA3 | |
| Interaction | HNF1B interactions | 2.78e-04 | 190 | 14 | 3 | int:HNF1B | |
| Interaction | RCOR1 interactions | 2.94e-04 | 494 | 14 | 4 | int:RCOR1 | |
| Interaction | PML interactions | 2.97e-04 | 933 | 14 | 5 | int:PML | |
| Interaction | ZSCAN5A interactions | 3.11e-04 | 38 | 14 | 2 | int:ZSCAN5A | |
| Interaction | TBL1Y interactions | 3.44e-04 | 40 | 14 | 2 | int:TBL1Y | |
| Interaction | SMC5 interactions | 4.09e-04 | 1000 | 14 | 5 | int:SMC5 | |
| Interaction | CBFA2T2 interactions | 4.36e-04 | 45 | 14 | 2 | int:CBFA2T2 | |
| Interaction | TERF2IP interactions | 4.48e-04 | 552 | 14 | 4 | int:TERF2IP | |
| Interaction | USP44 interactions | 4.56e-04 | 46 | 14 | 2 | int:USP44 | |
| Interaction | NLE1 interactions | 4.74e-04 | 228 | 14 | 3 | int:NLE1 | |
| Interaction | BCL6 interactions | 4.81e-04 | 229 | 14 | 3 | int:BCL6 | |
| Interaction | GART interactions | 4.87e-04 | 230 | 14 | 3 | int:GART | |
| Interaction | NR1I3 interactions | 4.96e-04 | 48 | 14 | 2 | int:NR1I3 | |
| Interaction | NR1I2 interactions | 4.96e-04 | 48 | 14 | 2 | int:NR1I2 | |
| Interaction | ZBTB5 interactions | 5.17e-04 | 49 | 14 | 2 | int:ZBTB5 | |
| Interaction | IRF5 interactions | 6.28e-04 | 54 | 14 | 2 | int:IRF5 | |
| Interaction | RBPJ interactions | 6.50e-04 | 254 | 14 | 3 | int:RBPJ | |
| Interaction | C1D interactions | 6.75e-04 | 56 | 14 | 2 | int:C1D | |
| Interaction | RARG interactions | 7.24e-04 | 58 | 14 | 2 | int:RARG | |
| Interaction | TRIM37 interactions | 7.37e-04 | 630 | 14 | 4 | int:TRIM37 | |
| Interaction | SNRNP40 interactions | 7.69e-04 | 637 | 14 | 4 | int:SNRNP40 | |
| Interaction | CIAO1 interactions | 9.45e-04 | 289 | 14 | 3 | int:CIAO1 | |
| Interaction | KLF15 interactions | 9.54e-04 | 290 | 14 | 3 | int:KLF15 | |
| Interaction | GCM1 interactions | 9.94e-04 | 68 | 14 | 2 | int:GCM1 | |
| Interaction | NR1H2 interactions | 9.94e-04 | 68 | 14 | 2 | int:NR1H2 | |
| Interaction | SP7 interactions | 1.09e-03 | 304 | 14 | 3 | int:SP7 | |
| Interaction | CEBPA interactions | 1.12e-03 | 1245 | 14 | 5 | int:CEBPA | |
| Interaction | PPARG interactions | 1.12e-03 | 307 | 14 | 3 | int:PPARG | |
| Interaction | NFKB1 interactions | 1.12e-03 | 307 | 14 | 3 | int:NFKB1 | |
| Interaction | GUSBP5 interactions | 1.21e-03 | 75 | 14 | 2 | int:GUSBP5 | |
| Interaction | HDGF interactions | 1.28e-03 | 321 | 14 | 3 | int:HDGF | |
| Interaction | HLA-E interactions | 1.34e-03 | 79 | 14 | 2 | int:HLA-E | |
| Interaction | HDAC4 interactions | 1.37e-03 | 744 | 14 | 4 | int:HDAC4 | |
| Interaction | MIER1 interactions | 1.37e-03 | 80 | 14 | 2 | int:MIER1 | |
| Interaction | KLF8 interactions | 1.37e-03 | 329 | 14 | 3 | int:KLF8 | |
| Interaction | PRDM1 interactions | 1.51e-03 | 84 | 14 | 2 | int:PRDM1 | |
| Interaction | QPRT interactions | 1.51e-03 | 84 | 14 | 2 | int:QPRT | |
| Interaction | PGR interactions | 1.51e-03 | 84 | 14 | 2 | int:PGR | |
| Interaction | BACH2 interactions | 1.73e-03 | 90 | 14 | 2 | int:BACH2 | |
| Interaction | PPARA interactions | 1.81e-03 | 92 | 14 | 2 | int:PPARA | |
| Interaction | C6orf141 interactions | 1.81e-03 | 92 | 14 | 2 | int:C6orf141 | |
| Interaction | SOX10 interactions | 1.81e-03 | 92 | 14 | 2 | int:SOX10 | |
| Interaction | PAX6 interactions | 1.86e-03 | 366 | 14 | 3 | int:PAX6 | |
| Interaction | GANAB interactions | 1.89e-03 | 368 | 14 | 3 | int:GANAB | |
| Interaction | CDKN1A interactions | 2.00e-03 | 375 | 14 | 3 | int:CDKN1A | |
| Interaction | UGP2 interactions | 2.01e-03 | 97 | 14 | 2 | int:UGP2 | |
| Interaction | TLE3 interactions | 2.01e-03 | 376 | 14 | 3 | int:TLE3 | |
| Interaction | SOX2 interactions | 2.03e-03 | 1422 | 14 | 5 | int:SOX2 | |
| Interaction | CBFB interactions | 2.31e-03 | 104 | 14 | 2 | int:CBFB | |
| Interaction | MANSC1 interactions | 2.31e-03 | 104 | 14 | 2 | int:MANSC1 | |
| Interaction | DCAF12 interactions | 2.48e-03 | 108 | 14 | 2 | int:DCAF12 | |
| Interaction | IRF2BP2 interactions | 2.57e-03 | 110 | 14 | 2 | int:IRF2BP2 | |
| Interaction | EN1 interactions | 2.57e-03 | 110 | 14 | 2 | int:EN1 | |
| Interaction | PAX8 interactions | 2.62e-03 | 111 | 14 | 2 | int:PAX8 | |
| Interaction | THRA interactions | 2.62e-03 | 111 | 14 | 2 | int:THRA | |
| Interaction | RANBP3 interactions | 2.67e-03 | 112 | 14 | 2 | int:RANBP3 | |
| Interaction | MARCHF4 interactions | 2.67e-03 | 112 | 14 | 2 | int:MARCHF4 | |
| Interaction | TBR1 interactions | 2.71e-03 | 113 | 14 | 2 | int:TBR1 | |
| Cytoband | 2q37.3 | 2.87e-04 | 77 | 15 | 2 | 2q37.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q24 | 1.74e-03 | 191 | 15 | 2 | chr11q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q37 | 2.43e-03 | 226 | 15 | 2 | chr2q37 | |
| GeneFamily | Aquaporins | 4.32e-05 | 14 | 13 | 2 | 305 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 6.44e-04 | 53 | 13 | 2 | 532 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.81e-05 | 181 | 15 | 3 | 576da14ab3107f89e1f44a4a439d1bef5bb42370 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Acinar_Adenocarcinoma-8|TCGA-Lung / Sample_Type by Project: Shred V9 | 4.84e-04 | 98 | 15 | 2 | 057b92cb485dbe25fe8911e2c43714f706751557 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Acinar_Adenocarcinoma|TCGA-Lung / Sample_Type by Project: Shred V9 | 6.65e-04 | 115 | 15 | 2 | eae0227fbdffe41656d924d74dc885d7f5d5f73d | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-8|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 8.23e-04 | 128 | 15 | 2 | 68f769ab707ac40b17cc9b106e147b214303faeb | |
| ToppCell | Epithelial-B_(AT1-AT2-progenitors)|World / shred on cell class and cell subclass (v4) | 1.07e-03 | 146 | 15 | 2 | 4511916904c1fac252cb68e871b782207f8137b3 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo-Trm_Tgd|Liver / Manually curated celltypes from each tissue | 1.19e-03 | 154 | 15 | 2 | c6308074468235c88ef4ea43ab155d9f86cbf261 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_B-Naive_B_cells|Lung / Manually curated celltypes from each tissue | 1.19e-03 | 154 | 15 | 2 | 2b7d7f09c75bbc22de1358fc44b8ad5d3f656617 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_1|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.20e-03 | 155 | 15 | 2 | a4ff78e2efc6fe9a513bb2b64e5848f2ce65a09f | |
| ToppCell | PBMC-Mild-cDC_3|Mild / Compartment, Disease Groups and Clusters | 1.25e-03 | 158 | 15 | 2 | 5fefab4831687cd8dd45f5cc84f681398069c3be | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-basal_intermediate_|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.25e-03 | 158 | 15 | 2 | 98712ed7e8e65e8c5ff9318cf0e0a04e271a055d | |
| ToppCell | droplet-Marrow-nan-21m-Hematologic-erythroid_progenitor|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-03 | 162 | 15 | 2 | d0ffebf5adee8a3ac9b81a4b793184f54010489a | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.31e-03 | 162 | 15 | 2 | d0d9c18a73bc0bf4f38308ef2eee8ae20f6a7918 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.31e-03 | 162 | 15 | 2 | 06f5d6c0bb26fe9d5180bc2ebf2c54bf52e715f3 | |
| ToppCell | P15-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.39e-03 | 167 | 15 | 2 | 5c3d0763f73628c71c71f9883556bb4f1639f3cc | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.46e-03 | 171 | 15 | 2 | c3e3ea09c73050372314a89b282e36ba5f339d73 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.51e-03 | 174 | 15 | 2 | ebe6ce173ad12d4a2afa39f8d6185c0e4f97fb1e | |
| ToppCell | 368C-Epithelial_cells-Epithelial-B_(AT2)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.56e-03 | 177 | 15 | 2 | ac8f774596068e66c0a9ea8a318be0ce5f5df834 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-B_(AT2)|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.56e-03 | 177 | 15 | 2 | d9c4a93b0e04a13bf39992dd1c1ec8df2c5f89fe | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.56e-03 | 177 | 15 | 2 | 36b5d29caa9cffbc0284f771a4db71aa72171a89 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_naive-9|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.56e-03 | 177 | 15 | 2 | ae55773c531099a9e94f44f01ba48b5e71dddc53 | |
| ToppCell | facs|World / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-03 | 179 | 15 | 2 | 8001db3044e8657980e24422377c4fdb0d7b323e | |
| ToppCell | 3'_v3-Lung-Lymphocytic_B|Lung / Manually curated celltypes from each tissue | 1.62e-03 | 180 | 15 | 2 | 237a2130a3f48595dad2417539c21e44585962b8 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.65e-03 | 182 | 15 | 2 | e97681a4102f3095d5d9e90ad70f1dc46e90983a | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT1-AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.65e-03 | 182 | 15 | 2 | cc79e0cc21e2fdc4ef77f052818d27b9f707aec1 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.65e-03 | 182 | 15 | 2 | d1a1feef318062f25493355d7beee8e5fb0e4206 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.67e-03 | 183 | 15 | 2 | ff6dde877659cde9daa3263db0932c9c9ef1adac | |
| ToppCell | PND07-28-samps-Epithelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.67e-03 | 183 | 15 | 2 | a98f1d71d82ed6cca996f74352ab834fb6e95206 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT1-AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.67e-03 | 183 | 15 | 2 | 06ac66726ec53db810ebb90ec69cfdb903da53f6 | |
| ToppCell | (4)_B_cells-(4)_B_mantle|(4)_B_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.67e-03 | 183 | 15 | 2 | 21b7fb6482eb1d5d31a4029e47e0992e8ddc8e2c | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.67e-03 | 183 | 15 | 2 | 807d64deaf4e50dccf6f831f88578a6d903c1421 | |
| ToppCell | COVID-19-Epithelial_cells-ECM-high_epithelial|COVID-19 / group, cell type (main and fine annotations) | 1.67e-03 | 183 | 15 | 2 | dc1d380bf7564f290256cb7108063d1bd2da732b | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_B-Naive_B_cells|GI_small-bowel / Manually curated celltypes from each tissue | 1.67e-03 | 183 | 15 | 2 | be294d22b91dbcf1e8d22e6a31c39b5caaad4751 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-03 | 183 | 15 | 2 | 07c18ccc45ddc9c22e482bd9ffb87f46ebcfe473 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-large_intestine_goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-03 | 183 | 15 | 2 | 5a936fb07074cec753bf19e3e3e52499605ea22c | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.69e-03 | 184 | 15 | 2 | cdf6f1c6cce97a7effa0c55959652e2c0b6992b3 | |
| ToppCell | Control-Epithelial_alveolar-AT_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.69e-03 | 184 | 15 | 2 | 51e129b3fcc2df083eda05a3afe3717218b1e52b | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.69e-03 | 184 | 15 | 2 | 7cc5796557379c3d1db078c1aeda40659c6e401c | |
| ToppCell | IPF-Myeloid-DC_Langerhans|Myeloid / Disease state, Lineage and Cell class | 1.70e-03 | 185 | 15 | 2 | ced17f69486591c3cbbdc852a3e82c3f3a4a30d7 | |
| ToppCell | PND01-03-samps-Epithelial|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.70e-03 | 185 | 15 | 2 | 2b854df79cfe2cb4d2f9c2938a066e0aa3649325 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT1-AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.70e-03 | 185 | 15 | 2 | 3bef59cc0aa939d2a7e52f0f6c61bc00528fe50b | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.70e-03 | 185 | 15 | 2 | 0c247a3f394c42e2a6f67fee3d9cf33096fecd13 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-AT1-AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.70e-03 | 185 | 15 | 2 | 68f428e169cfb77de970bdfdeea9b9f16f68d2ba | |
| ToppCell | Control-Epithelial_alveolar-AT_2-AT2_Progenitor|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.70e-03 | 185 | 15 | 2 | 8ca1374501eca01d8468130b74d50abfd4329fbe | |
| ToppCell | LPS_only-Epithelial_alveolar|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.72e-03 | 186 | 15 | 2 | e0a2ea4b46af742bc7c9b2072bb85e27d5c92712 | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Proliferative_AT2_Progenitor|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.74e-03 | 187 | 15 | 2 | e986901f5a1e09cbc9ba37e3c62845ff90ceda95 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.74e-03 | 187 | 15 | 2 | 201ff693e4756ee3e44762885b3a303a77eb535b | |
| ToppCell | PND01-03-samps-Epithelial-Alveolar_epithelial|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.74e-03 | 187 | 15 | 2 | 23fe3cdd6cc9b067086a8392d104186d300298ea | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.74e-03 | 187 | 15 | 2 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.74e-03 | 187 | 15 | 2 | ff26a533d310126521efe1d05cf8b9d32e524550 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.76e-03 | 188 | 15 | 2 | d8decd9b5967873ca8320c2f9f07365f163c777f | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.76e-03 | 188 | 15 | 2 | 43a0508d2524a5b310e89e9422843dcaab999bc3 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.78e-03 | 189 | 15 | 2 | 886dceacf96e2b6750c146a381da0bf96a2bb15b | |
| ToppCell | Adult|World / Lineage, Cell type, age group and donor | 1.78e-03 | 189 | 15 | 2 | 5cd285bfad973125d46d704fec18b21266a63379 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.78e-03 | 189 | 15 | 2 | 5f1f4321939877374a8ee13de93f2d1390af8e2e | |
| ToppCell | droplet-Lung-18m-Epithelial-alveolar_epithelial-type_II_pneumocyte-type_2_alveolar_epithelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.80e-03 | 190 | 15 | 2 | a51405f8466fc6d4087873137472619b2e84c1da | |
| ToppCell | Fibroblasts-CD55+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.80e-03 | 190 | 15 | 2 | b4088128f5acf53f43244c9af9fe44e033f1a57a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.80e-03 | 190 | 15 | 2 | 60bb6aaea9691d07295f61c14d1650f5041a0f9c | |
| ToppCell | droplet-Lung-18m-Epithelial-alveolar_epithelial-type_II_pneumocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.80e-03 | 190 | 15 | 2 | 059beca1c92181b8ba4dcd6fc71ff7530d83d0de | |
| ToppCell | facs-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-03 | 191 | 15 | 2 | c06bbad24e4897b2c3b5015e4de02411ebf75367 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.82e-03 | 191 | 15 | 2 | b374676ac90572d65895052d46469906e2b6fd93 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-03 | 191 | 15 | 2 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-SMG_Basal/Duct|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.82e-03 | 191 | 15 | 2 | 30e7cc5f7eadf90ab0900a73fdfe48f9a1adcbfb | |
| ToppCell | droplet-Lung-18m-Epithelial-alveolar_epithelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.82e-03 | 191 | 15 | 2 | caed913e7ede9f8ae3af273d1ecf375de6c5e813 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.82e-03 | 191 | 15 | 2 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-03 | 191 | 15 | 2 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-03 | 191 | 15 | 2 | 5f43f98cfe7a08d61ed55f34808fabfe47f1ac2e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-03 | 191 | 15 | 2 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-SMG_Basal/Duct-SMG_Basal/Duct|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.82e-03 | 191 | 15 | 2 | 41d2f5278f6d5f52a5bdf4f3df70969481c00162 | |
| ToppCell | wk_15-18-Endothelial-Lymph_endothelial-Intermediate_lymphatic_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.82e-03 | 191 | 15 | 2 | d25ac3206fe205a100cfee26431ff32c14c1938f | |
| ToppCell | 3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell-SMG_duct|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.83e-03 | 192 | 15 | 2 | c227ab1914191e839fc39c9adc2080026d4b04fc | |
| ToppCell | PND03-Epithelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.83e-03 | 192 | 15 | 2 | d8c23693f690d4d568585537bbfedda05d505b3d | |
| ToppCell | facs-Lung-nan-3m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-03 | 192 | 15 | 2 | cca2d0fedfbd946c54d6f4fc45887117c8dae58a | |
| ToppCell | 3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell-SMG_duct-SMG_duct_L.0.6.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.83e-03 | 192 | 15 | 2 | bf187a57a559ab732bb815892af45ca922966ac6 | |
| ToppCell | 3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.83e-03 | 192 | 15 | 2 | f573b2d205bd4d053a548af3fe3ff9de7be0cd2b | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B-Naive_B_cells|bone_marrow / Manually curated celltypes from each tissue | 1.83e-03 | 192 | 15 | 2 | fa99243ff028498c6a67d207a93e02c48e69cd42 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-03 | 192 | 15 | 2 | 967122c53af25b8f19a8411b4553d764c8d51c4d | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.83e-03 | 192 | 15 | 2 | 29f49f00770c991b5f27e4cb701dd2d2d6cb7178 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.85e-03 | 193 | 15 | 2 | 5dfa69a680a0859900141c40a446d217aaa747d3 | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.85e-03 | 193 | 15 | 2 | c1817ad675b9f9d2d3436c8b9646edf89f0d4c82 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-mature_enterocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.85e-03 | 193 | 15 | 2 | 32eb026d4317c1499d51294d396dfd5f293f9deb | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.85e-03 | 193 | 15 | 2 | ebea35704ac5d21e947ae094313cf2a5205e7014 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-mature_enterocytic-Colonocyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.85e-03 | 193 | 15 | 2 | 930df79b0600f43617052313294be33bcf5631f0 | |
| ToppCell | facs-Lung-3m-Epithelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.85e-03 | 193 | 15 | 2 | db5e43e0b571737e7006365bdf0575340b8b900b | |
| ToppCell | E16.5-samps-Epithelial|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.85e-03 | 193 | 15 | 2 | 1cb5a1cffa2b4a3bfecca16b791c1992edeb237d | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B-Naive_B_cells|lymph-node_spleen / Manually curated celltypes from each tissue | 1.87e-03 | 194 | 15 | 2 | 20967afbadb3cf80ba9f4d7ebda4e64389252e70 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.87e-03 | 194 | 15 | 2 | 07d8e38cbc2c7f0564c14f7c365f345f901b73b2 | |
| ToppCell | ASK452-Endothelial-Lymphatic|Endothelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.89e-03 | 195 | 15 | 2 | 20f492299a684ac1b7dd1bbc36a533cd6f9a1c93 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.91e-03 | 196 | 15 | 2 | 7a4d502550e9e37dc42f2ff1be3c896afe365d7f | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.91e-03 | 196 | 15 | 2 | a52879a4c822c5e4be569f01f845a795e00c5f4b | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Epithelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.91e-03 | 196 | 15 | 2 | 53dcac5e34c08c67a897dd5fbfbe88ea37e15585 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.91e-03 | 196 | 15 | 2 | cd8c22c6f52f068a33525723108d6b5b23fe822d | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.93e-03 | 197 | 15 | 2 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Epithelial-mature_enterocytic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.93e-03 | 197 | 15 | 2 | 755a53d4206354583bc5b76b63a0b1c9892b7382 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 1.93e-03 | 197 | 15 | 2 | f870a26f322668781e3d2832c5d9ef2c7c91011f | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.93e-03 | 197 | 15 | 2 | a137412f29a06e29efe8a5dd641839ff2aeeda0c | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 1.93e-03 | 197 | 15 | 2 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | AT2_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 1.93e-03 | 197 | 15 | 2 | 5e0d222872a25bb9e9069d3dffda2844bb69874a | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2|Control_saline / Treatment groups by lineage, cell group, cell type | 1.93e-03 | 197 | 15 | 2 | b8f62fcd6eb8f47b3cc41f616126f82c68a36e87 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-mature_enterocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.93e-03 | 197 | 15 | 2 | a6a27e5809ee2c9b56c7e06c35e4f140f9fa13ad | |
| ToppCell | ASK452-Epithelial-Transformed_epithelium|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.93e-03 | 197 | 15 | 2 | b22a79a5922c865a360e2afc5506a08a512fa76a | |
| Drug | halofenate | 2.43e-06 | 4 | 15 | 2 | CID000033584 | |
| Drug | tetraiodothyroacetic acid | 1.45e-05 | 9 | 15 | 2 | ctd:C011126 | |
| Drug | diclazuril | 1.45e-05 | 9 | 15 | 2 | CID000456389 | |
| Drug | Androstenols | 2.66e-05 | 12 | 15 | 2 | ctd:D000737 | |
| Drug | dexamethasone oxetanone | 2.66e-05 | 12 | 15 | 2 | CID000063042 | |
| Drug | telL | 1.20e-04 | 25 | 15 | 2 | CID000101525 | |
| Drug | lithocholic acid acetate | 1.30e-04 | 26 | 15 | 2 | ctd:C502354 | |
| Drug | thalicarpine | 1.99e-04 | 32 | 15 | 2 | CID000021470 | |
| Drug | Homochlorcyclizine dihydrochloride [1982-36-1]; Up 200; 10.4uM; PC3; HT_HG-U133A | 2.20e-04 | 184 | 15 | 3 | 7295_UP | |
| Drug | DR-0 | 2.38e-04 | 35 | 15 | 2 | CID010062716 | |
| Drug | discodermolide | 2.38e-04 | 35 | 15 | 2 | CID000643668 | |
| Drug | 1kkq | 2.52e-04 | 36 | 15 | 2 | CID000446738 | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.57e-04 | 194 | 15 | 3 | 7001_DN | |
| Drug | Suramin sodium salt; Down 200; 10uM; PC3; HT_HG-U133A | 2.57e-04 | 194 | 15 | 3 | 7529_DN | |
| Drug | Ethoxyquin [91-53-2]; Up 200; 18.4uM; MCF7; HT_HG-U133A | 2.57e-04 | 194 | 15 | 3 | 3846_UP | |
| Drug | Ofloxacin [82419-36-1]; Up 200; 11uM; PC3; HT_HG-U133A | 2.61e-04 | 195 | 15 | 3 | 7372_UP | |
| Drug | Tocainide hydrochloride; Down 200; 17.4uM; MCF7; HT_HG-U133A | 2.61e-04 | 195 | 15 | 3 | 7351_DN | |
| Drug | Sulfadimethoxine [122-11-2]; Down 200; 12.8uM; PC3; HT_HG-U133A | 2.65e-04 | 196 | 15 | 3 | 3702_DN | |
| Drug | Debrisoquin sulfate [581-88-4]; Up 200; 9uM; MCF7; HT_HG-U133A | 2.65e-04 | 196 | 15 | 3 | 5288_UP | |
| Drug | baccatin III | 2.66e-04 | 37 | 15 | 2 | CID000065366 | |
| Drug | Pantothenic acid calcium salt monohydrate [63409-48-3]; Down 200; 8uM; PC3; HT_HG-U133A | 2.69e-04 | 197 | 15 | 3 | 4189_DN | |
| Drug | Lorglumide sodium salt [97964-56-2]; Down 200; 8.4uM; PC3; HT_HG-U133A | 2.69e-04 | 197 | 15 | 3 | 4658_DN | |
| Drug | Riluzole hydrochloride; Up 200; 14.8uM; PC3; HT_HG-U133A | 2.69e-04 | 197 | 15 | 3 | 7365_UP | |
| Drug | Pyridoxine hydrochloride [58-56-0]; Up 200; 19.4uM; MCF7; HT_HG-U133A | 2.69e-04 | 197 | 15 | 3 | 2751_UP | |
| Drug | Suprofen [40828-46-4]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 2.69e-04 | 197 | 15 | 3 | 3343_DN | |
| Drug | 3-hydroxy-(D/L)-kynurenine; Up 200; 9.2uM; MCF7; HT_HG-U133A_EA | 2.69e-04 | 197 | 15 | 3 | 1109_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 500uM; MCF7; HG-U133A | 2.73e-04 | 198 | 15 | 3 | 347_DN | |
| Drug | Gabapentin [60142-96-3]; Down 200; 23.4uM; MCF7; HT_HG-U133A | 2.73e-04 | 198 | 15 | 3 | 3472_DN | |
| Drug | Isocorydine (+) [475-67-2]; Up 200; 11.8uM; HL60; HG-U133A | 2.73e-04 | 198 | 15 | 3 | 1787_UP | |
| Drug | Flufenamic acid [530-78-9]; Down 200; 14.2uM; PC3; HT_HG-U133A | 2.73e-04 | 198 | 15 | 3 | 5059_DN | |
| Drug | Mephentermine hemisulfate [1212-72-2]; Up 200; 9.4uM; PC3; HT_HG-U133A | 2.77e-04 | 199 | 15 | 3 | 7384_UP | |
| Drug | Roxithromycin [80214-83-1]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 2.77e-04 | 199 | 15 | 3 | 4778_UP | |
| Drug | 6-thioguanine; Up 200; 10uM; MCF7; HG-U133A | 2.81e-04 | 200 | 15 | 3 | 642_UP | |
| Drug | p-fluorophenylalanine | 3.11e-04 | 40 | 15 | 2 | CID000004654 | |
| Drug | AC1L9KZ2 | 4.49e-04 | 48 | 15 | 2 | CID000447561 | |
| Drug | Lithocholic Acid | 4.79e-04 | 240 | 15 | 3 | ctd:D008095 | |
| Drug | AC1O5TPK | 5.07e-04 | 51 | 15 | 2 | CID006440511 | |
| Drug | AC1LA6KT | 5.07e-04 | 51 | 15 | 2 | CID000508110 | |
| Disease | Hamman-Rich syndrome | 2.19e-05 | 14 | 15 | 2 | C0085786 | |
| Disease | Idiopathic Pulmonary Fibrosis | 5.04e-05 | 21 | 15 | 2 | C1800706 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 2.80e-04 | 49 | 15 | 2 | DOID:0060037 (implicated_via_orthology) | |
| Disease | Alveolitis, Fibrosing | 8.02e-04 | 83 | 15 | 2 | C4721507 | |
| Disease | Pulmonary Fibrosis | 8.40e-04 | 85 | 15 | 2 | C0034069 | |
| Disease | breast cancer (is_marker_for) | 3.89e-03 | 185 | 15 | 2 | DOID:1612 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FQRNLFYGQKNKYRA | 246 | Q8IXF9 | |
| AHYCKKYNIQYQENF | 1281 | Q99758 | |
| FQRNLFYGQKNKYRA | 246 | A6NM10 | |
| KCQNFHYKENQYFHV | 366 | Q7Z5J8 | |
| VSQCKNFYFNYKKRQ | 646 | Q9Y618 | |
| QYKRYLNSQQQYFHR | 131 | Q6P4R8 | |
| YQKQQQQREYRFRHF | 101 | Q9Y2G8 | |
| GAQRCQHYKFRYHQQ | 2481 | Q9UMN6 | |
| KQLRNYRDNYQAFCK | 886 | P15924 | |
| QCKNFYFNYKRRHNL | 661 | O75376 | |
| NFFNNYKTYRKLHPN | 276 | P15907 | |
| AKNYRHLCAVYYNKN | 491 | Q9NSD9 | |
| ANNCIFYKNHRAYTR | 901 | Q0P6D6 | |
| QKYNHCRVKIYTFNQ | 176 | Q16851 | |
| YRARHQKCNFRIFYN | 551 | Q96HI0 |